5,867 Shares in HCA Healthcare, Inc. $HCA Bought by North Dakota State Investment Board

North Dakota State Investment Board bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the fourth quarter, Holdings Channel reports. The fund bought 5,867 shares of the company’s stock, valued at approximately $2,739,000.

A number of other institutional investors have also recently added to or reduced their stakes in HCA. Viking Global Investors LP grew its holdings in HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after acquiring an additional 690,773 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in HCA Healthcare by 4,545.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock worth $309,686,000 after purchasing an additional 649,058 shares during the last quarter. Danske Bank A S bought a new position in HCA Healthcare during the 3rd quarter worth approximately $115,530,000. Zurich Insurance Group Ltd FI raised its holdings in HCA Healthcare by 3,755.9% during the 3rd quarter. Zurich Insurance Group Ltd FI now owns 269,912 shares of the company’s stock worth $115,036,000 after purchasing an additional 262,912 shares during the last quarter. Finally, Mondrian Investment Partners LTD bought a new position in HCA Healthcare during the 3rd quarter worth approximately $106,605,000. 62.73% of the stock is owned by institutional investors.

Insider Activity at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the sale, the executive vice president directly owned 8,853 shares in the company, valued at $4,721,924.61. The trade was a 16.06% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.50% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on HCA shares. Argus lowered their price target on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a report on Monday, May 4th. KeyCorp reduced their price objective on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of HCA Healthcare in a research report on Friday, March 27th. UBS Group raised their price objective on shares of HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a research report on Monday, February 23rd. Finally, Truist Financial reduced their price target on shares of HCA Healthcare from $546.00 to $535.00 and set a “buy” rating for the company in a research report on Monday, April 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $517.82.

HCA Healthcare Price Performance

HCA opened at $422.60 on Tuesday. The company has a market capitalization of $93.75 billion, a price-to-earnings ratio of 14.53, a P/E/G ratio of 1.34 and a beta of 1.18. The firm’s fifty day moving average price is $476.49 and its two-hundred day moving average price is $485.66. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The firm had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.HCA Healthcare’s revenue was up 4.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s payout ratio is presently 10.73%.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.